Dr. H. Bliss Murphy Cancer Centre

The trials here

What the 8 trials at this site are about, from their registry records.

Conditions

• Head and neck cancer1 trial
• Hodgkin lymphoma1 trial
• Liver and biliary tract cancer1 trial
• Lung cancer1 trial
• Metastatic breast cancer1 trial
• Multiple myeloma1 trial
• Ovarian cancer1 trial
• Prostate cancer1 trial

Phase

• Phase 24 trials
• Phase 33 trials

Status

• Completed3 trials
• Active, not recruiting2 trials
• Recruiting2 trials
• Terminated1 trial

Lead sponsor

• Canadian Cancer Trials Group7 trials
• Canadian Urologic Oncology Group1 trial

Running trials

• Recruiting

  Fixed Duration vs Continuous Anti-CD38 Antibody Therapy Among Transplant Ineligible Older Adults With Newly-Diagnosed Multiple Myeloma

  NCT06182774· Phase 3· Canadian Cancer Trials Group· Source

  Contact: Debra Bergstrom

• Recruiting

  Pembrolizumab and Brentuximab Vedotin vs GDP and Stem Cell Transplant for Relapsed/Refractory Hodgkin Lymphoma

  NCT05180097· Phase 2· Canadian Cancer Trials Group· Source

  Contact: Jacqueline Costello

• Active, not recruiting

  De-Escalation Radiotherapy in Patients With Low-Risk HPV-Related Oropharyngeal Squamous Cell Carcinoma

  NCT03822897· Phase 2· Canadian Cancer Trials Group· Source

• Active, not recruiting

  ASA in Prevention of Ovarian Cancer (STICs and STONEs)

  NCT03480776· Phase 2· Canadian Cancer Trials Group· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Hodgkin lymphoma1 recruiting
• Multiple myeloma1 recruiting

Closed trials

• Terminated

  Metformin in Patients Initiating ADT as Prevention and Intervention of Metabolic Syndrome

  NCT03031821· Phase 3· Canadian Urologic Oncology Group· Source

• Completed

  Two Different Schedules of Palbociclib + Second Line Endocrine Therapy in Estrogen Receptor Positive, HER2 Neg Advanced/Metastatic Breast Cancer

  NCT02630693· Phase 2· Canadian Cancer Trials Group· Source

• Completed

  Study of Palliative Radiotherapy for Symptomatic Hepatocellular Carcinoma and Liver Metastases

  NCT02511522· Canadian Cancer Trials Group· Source

• Completed

  Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLC

  NCT02273375· Phase 3· Canadian Cancer Trials Group· Source